DePuy Synthes to acquire Gemtrack technology from MinMaxMedical

DePuy Synthes announced a definitive agreement to acquire selective rights to develop, manufacture and commercialize Gemtrack technology from MinMaxMedical for use across its Joints portfolio, including shoulder, hip and knee, for navigation and robotic applications.

“This new collaboration will be applied broadly to the VELYS ecosystem to reduce the reliance on line-of-sight dependent navigation and offering the potential for improved navigation precision.”jnj.com

• 3 sources
• jnj.comDePuy Synthes Announces Agreement to Acquire Miniature Radiofrequency Tracking Technology Across its Joint Reconstruction PortfolioMay 26, 2026
• g-medtech.comDePuy Synthes Announces Two Strategic Agreements to Expand Orthopaedic Portfolio - News CenterMay 27, 2026
• healthindustryhub.com.auDePuy Synthes strikes deal ahead of split from Johnson & Johnson - Health Industry HubHealth Industry HubJun 16, 2026

Summarized from public sources; check the original articles before acting on it.